跳至主要内容
临床试验/IRCT20180103038199N16
IRCT20180103038199N16招募中2 期

Evaluation of the effectiveness of ellagic acid on liver steatosis in patients with non-alcoholic fatty liver disease

Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • Age between 30-65 years old
  • Body composition index between 25-35
  • Diagnosis of liver steatosis by two-dimensional elastography (grade 2 and above)
  • Fatty liver patients with grade F0 and F1

排除标准

  • Viral hepatitis (especially hepatitis C)
  • Alcoholic fatty liver or consumption of alcohol
  • Diseases such as Wilson's disease, hemochromatosis, celiac disease, cirrhosis, biliary obstruction and primary biliary cirrhosis
  • Special nutritional conditions such as starvation, fasting, and intravenous feeding
  • Breastfeeding or pregnancy
  • History of hypersensitivity to pomegranate and its products
  • Taking any kind of herbal supplements
  • Fatty liver patients with grade F2, F3, F4

研究者

相似试验